Schering Corporation
Berlin and Bergkamen· latest recorded location
Schering Corporation is named on 10 US grants and 614 published applications in this corpus. Its most frequent classification is A61P (Therapeutic uses of medicines).
- Granted patents
- 10
- Published applications
- 614
- Inventors
- 900
- Granted in 2026 so far
- 0
- Most recent grant
- 29 Jun 1999
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 1 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 2 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 2 | 0 |
| 1997 | 0 | 0 |
| 1998 | 2 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 21 |
| 2003 | 0 | 69 |
| 2004 | 0 | 75 |
| 2005 | 0 | 56 |
| 2006 | 0 | 100 |
| 2007 | 0 | 84 |
| 2008 | 0 | 56 |
| 2009 | 0 | 52 |
| 2010 | 0 | 77 |
| 2011 | 0 | 19 |
| 2012 | 0 | 5 |
By publication year.
Technology areas
Share of 624 documents
- A61PTherapeutic uses of medicines495
- C07DHeterocyclic compounds333
- A61KMedicines and medical preparations254
- C07KPeptides123
- C07CAcyclic or carbocyclic compounds43
- C12NMicroorganisms or enzymes33
- G01NInvestigating or analysing materials by determining their chemical or physical properties26
- Y02ATechnologies for adaptation to climate change13
- Y02PLow-carbon manufacturing12
- C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms10
Recent patents
- Process of making solid ribavirin dosage forms29 Jun 1999US 5,916,594 A
- Hybrid DNA prepared binding composition24 Nov 1998US 5,840,545 A
- Sulfur-substituted azetidinone compounds useful as hypocholesterolemic agents28 Apr 1998US 5,744,467 A
- Anti-HIV (AIDS) agents14 May 1996US 5,516,784 A
- 4-substituted pyrazoloquinoline derivatives9 Apr 1996US 5,506,236 A
- Antibody purification8 Nov 2012US 2012/0282654 A1
- Thiophenes as glucagon receptor antagonists, compositions, and methods for their use3 May 2012US 2012/0108505 A1
- Nasal spray device9 Feb 2012US 2012/0031398 A1
- Light blocking container with viewing window for photosensitive compounds9 Feb 2012US 2012/0031401 A1
- Light blocking container with content viewing window and contrast background2 Feb 2012US 2012/0024742 A1
Most cited
By later US patents
- Benzopyrido piperidine, piperidylidene and piperazine compounds, compositions, methods of manufacture and methods of use39US 5,104,876 A1992
- Sulfur-substituted azetidinone compounds useful as hypocholesterolemic agents32US 5,744,467 A1998
- 1,2,4-Oxadiazole derivatives and herbicide composition containing same14US 4,243,409 A1981
- Anti-HIV (AIDS) agents14US 5,516,784 A1996
- 4-substituted pyrazoloquinoline derivatives5US 5,506,236 A1996